世界の胃がん検査・治療・予防市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Gastric Cancer Testing, Treatment and Prevention Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-3461 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、106ページ • 納品方法：Eメール（納期：3日） • 産業分類：産業装置

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、胃がん検査・治療・予防の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（検査、治療、予防）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・胃がん検査・治療・予防の市場動向 ・企業の競争状況、市場シェア ・胃がん検査・治療・予防の種類別市場規模と予測2016-2027（検査、治療、予防） ・胃がん検査・治療・予防の用途別市場規模と予測2016-2027（病院、診療所、その他） ・胃がん検査・治療・予防の北米市場規模2016-2027（アメリカ、カナダ） ・胃がん検査・治療・予防の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・胃がん検査・治療・予防のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・胃がん検査・治療・予防の中南米市場規模2016-2027（メキシコ、ブラジル） ・胃がん検査・治療・予防の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Biogen Idec、Bristol Myers Squibb、Eli Lilly And Company、Glaxosmithkline Genentech, Inc、Hoffmann-La Roche Inc.、Immunogen Merck & Company、Novartis、Pacific Edge Diagnostics Nz、Pfizer、Roche/Genentech Oncolytics、Zova Biotherapeutics Inc.） ・結論

Market Analysis and Insights: Global Gastric Cancer Testing, Treatment and Prevention Market
The global Gastric Cancer Testing, Treatment and Prevention market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Gastric Cancer Testing, Treatment and Prevention market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Gastric Cancer Testing, Treatment and Prevention market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Gastric Cancer Testing, Treatment and Prevention market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Gastric Cancer Testing, Treatment and Prevention market.

Global Gastric Cancer Testing, Treatment and Prevention Scope and Market Size
Gastric Cancer Testing, Treatment and Prevention market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Gastric Cancer Testing, Treatment and Prevention market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Test
Treatment
Prevention

Segment by Application
Hospitals
Clinics
Other

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Biogen Idec
Bristol Myers Squibb
Eli Lilly And Company
Glaxosmithkline Genentech, Inc
Hoffmann-La Roche Inc.
Immunogen Merck & Company
Novartis
Pacific Edge Diagnostics Nz
Pfizer
Roche/Genentech Oncolytics
Zova Biotherapeutics Inc.

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gastric Cancer Testing, Treatment and Prevention Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Test
1.2.3 Treatment
1.2.4 Prevention
1.3 Market by Application
1.3.1 Global Gastric Cancer Testing, Treatment and Prevention Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Gastric Cancer Testing, Treatment and Prevention Market Perspective (2016-2027)
2.2 Gastric Cancer Testing, Treatment and Prevention Growth Trends by Regions
2.2.1 Gastric Cancer Testing, Treatment and Prevention Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Gastric Cancer Testing, Treatment and Prevention Historic Market Share by Regions (2016-2021)
2.2.3 Gastric Cancer Testing, Treatment and Prevention Forecasted Market Size by Regions (2022-2027)
2.3 Gastric Cancer Testing, Treatment and Prevention Industry Dynamic
2.3.1 Gastric Cancer Testing, Treatment and Prevention Market Trends
2.3.2 Gastric Cancer Testing, Treatment and Prevention Market Drivers
2.3.3 Gastric Cancer Testing, Treatment and Prevention Market Challenges
2.3.4 Gastric Cancer Testing, Treatment and Prevention Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Gastric Cancer Testing, Treatment and Prevention Players by Revenue
3.1.1 Global Top Gastric Cancer Testing, Treatment and Prevention Players by Revenue (2016-2021)
3.1.2 Global Gastric Cancer Testing, Treatment and Prevention Revenue Market Share by Players (2016-2021)
3.2 Global Gastric Cancer Testing, Treatment and Prevention Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Gastric Cancer Testing, Treatment and Prevention Revenue
3.4 Global Gastric Cancer Testing, Treatment and Prevention Market Concentration Ratio
3.4.1 Global Gastric Cancer Testing, Treatment and Prevention Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gastric Cancer Testing, Treatment and Prevention Revenue in 2020
3.5 Gastric Cancer Testing, Treatment and Prevention Key Players Head office and Area Served
3.6 Key Players Gastric Cancer Testing, Treatment and Prevention Product Solution and Service
3.7 Date of Enter into Gastric Cancer Testing, Treatment and Prevention Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Gastric Cancer Testing, Treatment and Prevention Breakdown Data by Type
4.1 Global Gastric Cancer Testing, Treatment and Prevention Historic Market Size by Type (2016-2021)
4.2 Global Gastric Cancer Testing, Treatment and Prevention Forecasted Market Size by Type (2022-2027)

5 Gastric Cancer Testing, Treatment and Prevention Breakdown Data by Application
5.1 Global Gastric Cancer Testing, Treatment and Prevention Historic Market Size by Application (2016-2021)
5.2 Global Gastric Cancer Testing, Treatment and Prevention Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Gastric Cancer Testing, Treatment and Prevention Market Size (2016-2027)
6.2 North America Gastric Cancer Testing, Treatment and Prevention Market Size by Type
6.2.1 North America Gastric Cancer Testing, Treatment and Prevention Market Size by Type (2016-2021)
6.2.2 North America Gastric Cancer Testing, Treatment and Prevention Market Size by Type (2022-2027)
6.2.3 North America Gastric Cancer Testing, Treatment and Prevention Market Size by Type (2016-2027)
6.3 North America Gastric Cancer Testing, Treatment and Prevention Market Size by Application
6.3.1 North America Gastric Cancer Testing, Treatment and Prevention Market Size by Application (2016-2021)
6.3.2 North America Gastric Cancer Testing, Treatment and Prevention Market Size by Application (2022-2027)
6.3.3 North America Gastric Cancer Testing, Treatment and Prevention Market Size by Application (2016-2027)
6.4 North America Gastric Cancer Testing, Treatment and Prevention Market Size by Country
6.4.1 North America Gastric Cancer Testing, Treatment and Prevention Market Size by Country (2016-2021)
6.4.2 North America Gastric Cancer Testing, Treatment and Prevention Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Gastric Cancer Testing, Treatment and Prevention Market Size (2016-2027)
7.2 Europe Gastric Cancer Testing, Treatment and Prevention Market Size by Type
7.2.1 Europe Gastric Cancer Testing, Treatment and Prevention Market Size by Type (2016-2021)
7.2.2 Europe Gastric Cancer Testing, Treatment and Prevention Market Size by Type (2022-2027)
7.2.3 Europe Gastric Cancer Testing, Treatment and Prevention Market Size by Type (2016-2027)
7.3 Europe Gastric Cancer Testing, Treatment and Prevention Market Size by Application
7.3.1 Europe Gastric Cancer Testing, Treatment and Prevention Market Size by Application (2016-2021)
7.3.2 Europe Gastric Cancer Testing, Treatment and Prevention Market Size by Application (2022-2027)
7.3.3 Europe Gastric Cancer Testing, Treatment and Prevention Market Size by Application (2016-2027)
7.4 Europe Gastric Cancer Testing, Treatment and Prevention Market Size by Country
7.4.1 Europe Gastric Cancer Testing, Treatment and Prevention Market Size by Country (2016-2021)
7.4.2 Europe Gastric Cancer Testing, Treatment and Prevention Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Gastric Cancer Testing, Treatment and Prevention Market Size (2016-2027)
8.2 Asia-Pacific Gastric Cancer Testing, Treatment and Prevention Market Size by Type
8.2.1 Asia-Pacific Gastric Cancer Testing, Treatment and Prevention Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Gastric Cancer Testing, Treatment and Prevention Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Gastric Cancer Testing, Treatment and Prevention Market Size by Type (2016-2027)
8.3 Asia-Pacific Gastric Cancer Testing, Treatment and Prevention Market Size by Application
8.3.1 Asia-Pacific Gastric Cancer Testing, Treatment and Prevention Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Gastric Cancer Testing, Treatment and Prevention Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Gastric Cancer Testing, Treatment and Prevention Market Size by Application (2016-2027)
8.4 Asia-Pacific Gastric Cancer Testing, Treatment and Prevention Market Size by Region
8.4.1 Asia-Pacific Gastric Cancer Testing, Treatment and Prevention Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Gastric Cancer Testing, Treatment and Prevention Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Gastric Cancer Testing, Treatment and Prevention Market Size (2016-2027)
9.2 Latin America Gastric Cancer Testing, Treatment and Prevention Market Size by Type
9.2.1 Latin America Gastric Cancer Testing, Treatment and Prevention Market Size by Type (2016-2021)
9.2.2 Latin America Gastric Cancer Testing, Treatment and Prevention Market Size by Type (2022-2027)
9.2.3 Latin America Gastric Cancer Testing, Treatment and Prevention Market Size by Type (2016-2027)
9.3 Latin America Gastric Cancer Testing, Treatment and Prevention Market Size by Application
9.3.1 Latin America Gastric Cancer Testing, Treatment and Prevention Market Size by Application (2016-2021)
9.3.2 Latin America Gastric Cancer Testing, Treatment and Prevention Market Size by Application (2022-2027)
9.3.3 Latin America Gastric Cancer Testing, Treatment and Prevention Market Size by Application (2016-2027)
9.4 Latin America Gastric Cancer Testing, Treatment and Prevention Market Size by Country
9.4.1 Latin America Gastric Cancer Testing, Treatment and Prevention Market Size by Country (2016-2021)
9.4.2 Latin America Gastric Cancer Testing, Treatment and Prevention Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Gastric Cancer Testing, Treatment and Prevention Market Size (2016-2027)
10.2 Middle East & Africa Gastric Cancer Testing, Treatment and Prevention Market Size by Type
10.2.1 Middle East & Africa Gastric Cancer Testing, Treatment and Prevention Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Gastric Cancer Testing, Treatment and Prevention Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Gastric Cancer Testing, Treatment and Prevention Market Size by Type (2016-2027)
10.3 Middle East & Africa Gastric Cancer Testing, Treatment and Prevention Market Size by Application
10.3.1 Middle East & Africa Gastric Cancer Testing, Treatment and Prevention Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Gastric Cancer Testing, Treatment and Prevention Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Gastric Cancer Testing, Treatment and Prevention Market Size by Application (2016-2027)
10.4 Middle East & Africa Gastric Cancer Testing, Treatment and Prevention Market Size by Country
10.4.1 Middle East & Africa Gastric Cancer Testing, Treatment and Prevention Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Gastric Cancer Testing, Treatment and Prevention Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Biogen Idec
11.1.1 Biogen Idec Company Details
11.1.2 Biogen Idec Business Overview
11.1.3 Biogen Idec Gastric Cancer Testing, Treatment and Prevention Introduction
11.1.4 Biogen Idec Revenue in Gastric Cancer Testing, Treatment and Prevention Business (2016-2021)
11.1.5 Biogen Idec Recent Development
11.2 Bristol Myers Squibb
11.2.1 Bristol Myers Squibb Company Details
11.2.2 Bristol Myers Squibb Business Overview
11.2.3 Bristol Myers Squibb Gastric Cancer Testing, Treatment and Prevention Introduction
11.2.4 Bristol Myers Squibb Revenue in Gastric Cancer Testing, Treatment and Prevention Business (2016-2021)
11.2.5 Bristol Myers Squibb Recent Development
11.3 Eli Lilly And Company
11.3.1 Eli Lilly And Company Company Details
11.3.2 Eli Lilly And Company Business Overview
11.3.3 Eli Lilly And Company Gastric Cancer Testing, Treatment and Prevention Introduction
11.3.4 Eli Lilly And Company Revenue in Gastric Cancer Testing, Treatment and Prevention Business (2016-2021)
11.3.5 Eli Lilly And Company Recent Development
11.4 Glaxosmithkline Genentech, Inc
11.4.1 Glaxosmithkline Genentech, Inc Company Details
11.4.2 Glaxosmithkline Genentech, Inc Business Overview
11.4.3 Glaxosmithkline Genentech, Inc Gastric Cancer Testing, Treatment and Prevention Introduction
11.4.4 Glaxosmithkline Genentech, Inc Revenue in Gastric Cancer Testing, Treatment and Prevention Business (2016-2021)
11.4.5 Glaxosmithkline Genentech, Inc Recent Development
11.5 Hoffmann-La Roche Inc.
11.5.1 Hoffmann-La Roche Inc. Company Details
11.5.2 Hoffmann-La Roche Inc. Business Overview
11.5.3 Hoffmann-La Roche Inc. Gastric Cancer Testing, Treatment and Prevention Introduction
11.5.4 Hoffmann-La Roche Inc. Revenue in Gastric Cancer Testing, Treatment and Prevention Business (2016-2021)
11.5.5 Hoffmann-La Roche Inc. Recent Development
11.6 Immunogen Merck & Company
11.6.1 Immunogen Merck & Company Company Details
11.6.2 Immunogen Merck & Company Business Overview
11.6.3 Immunogen Merck & Company Gastric Cancer Testing, Treatment and Prevention Introduction
11.6.4 Immunogen Merck & Company Revenue in Gastric Cancer Testing, Treatment and Prevention Business (2016-2021)
11.6.5 Immunogen Merck & Company Recent Development
11.7 Novartis
11.7.1 Novartis Company Details
11.7.2 Novartis Business Overview
11.7.3 Novartis Gastric Cancer Testing, Treatment and Prevention Introduction
11.7.4 Novartis Revenue in Gastric Cancer Testing, Treatment and Prevention Business (2016-2021)
11.7.5 Novartis Recent Development
11.8 Pacific Edge Diagnostics Nz
11.8.1 Pacific Edge Diagnostics Nz Company Details
11.8.2 Pacific Edge Diagnostics Nz Business Overview
11.8.3 Pacific Edge Diagnostics Nz Gastric Cancer Testing, Treatment and Prevention Introduction
11.8.4 Pacific Edge Diagnostics Nz Revenue in Gastric Cancer Testing, Treatment and Prevention Business (2016-2021)
11.8.5 Pacific Edge Diagnostics Nz Recent Development
11.9 Pfizer
11.9.1 Pfizer Company Details
11.9.2 Pfizer Business Overview
11.9.3 Pfizer Gastric Cancer Testing, Treatment and Prevention Introduction
11.9.4 Pfizer Revenue in Gastric Cancer Testing, Treatment and Prevention Business (2016-2021)
11.9.5 Pfizer Recent Development
11.10 Roche/Genentech Oncolytics
11.10.1 Roche/Genentech Oncolytics Company Details
11.10.2 Roche/Genentech Oncolytics Business Overview
11.10.3 Roche/Genentech Oncolytics Gastric Cancer Testing, Treatment and Prevention Introduction
11.10.4 Roche/Genentech Oncolytics Revenue in Gastric Cancer Testing, Treatment and Prevention Business (2016-2021)
11.10.5 Roche/Genentech Oncolytics Recent Development
11.11 Zova Biotherapeutics Inc.
11.11.1 Zova Biotherapeutics Inc. Company Details
11.11.2 Zova Biotherapeutics Inc. Business Overview
11.11.3 Zova Biotherapeutics Inc. Gastric Cancer Testing, Treatment and Prevention Introduction
11.11.4 Zova Biotherapeutics Inc. Revenue in Gastric Cancer Testing, Treatment and Prevention Business (2016-2021)
11.11.5 Zova Biotherapeutics Inc. Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Gastric Cancer Testing, Treatment and Prevention Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Test
Table 3. Key Players of Treatment
Table 4. Key Players of Prevention
Table 5. Global Gastric Cancer Testing, Treatment and Prevention Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Gastric Cancer Testing, Treatment and Prevention Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Gastric Cancer Testing, Treatment and Prevention Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Gastric Cancer Testing, Treatment and Prevention Market Share by Regions (2016-2021)
Table 9. Global Gastric Cancer Testing, Treatment and Prevention Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Gastric Cancer Testing, Treatment and Prevention Market Share by Regions (2022-2027)
Table 11. Gastric Cancer Testing, Treatment and Prevention Market Trends
Table 12. Gastric Cancer Testing, Treatment and Prevention Market Drivers
Table 13. Gastric Cancer Testing, Treatment and Prevention Market Challenges
Table 14. Gastric Cancer Testing, Treatment and Prevention Market Restraints
Table 15. Global Gastric Cancer Testing, Treatment and Prevention Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Gastric Cancer Testing, Treatment and Prevention Market Share by Players (2016-2021)
Table 17. Global Top Gastric Cancer Testing, Treatment and Prevention Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gastric Cancer Testing, Treatment and Prevention as of 2020)
Table 18. Ranking of Global Top Gastric Cancer Testing, Treatment and Prevention Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Gastric Cancer Testing, Treatment and Prevention Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Gastric Cancer Testing, Treatment and Prevention Product Solution and Service
Table 22. Date of Enter into Gastric Cancer Testing, Treatment and Prevention Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Gastric Cancer Testing, Treatment and Prevention Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Gastric Cancer Testing, Treatment and Prevention Revenue Market Share by Type (2016-2021)
Table 26. Global Gastric Cancer Testing, Treatment and Prevention Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Gastric Cancer Testing, Treatment and Prevention Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Gastric Cancer Testing, Treatment and Prevention Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Gastric Cancer Testing, Treatment and Prevention Revenue Market Share by Application (2016-2021)
Table 30. Global Gastric Cancer Testing, Treatment and Prevention Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Gastric Cancer Testing, Treatment and Prevention Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Gastric Cancer Testing, Treatment and Prevention Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Gastric Cancer Testing, Treatment and Prevention Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Gastric Cancer Testing, Treatment and Prevention Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Gastric Cancer Testing, Treatment and Prevention Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Gastric Cancer Testing, Treatment and Prevention Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Gastric Cancer Testing, Treatment and Prevention Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Gastric Cancer Testing, Treatment and Prevention Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Gastric Cancer Testing, Treatment and Prevention Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Gastric Cancer Testing, Treatment and Prevention Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Gastric Cancer Testing, Treatment and Prevention Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Gastric Cancer Testing, Treatment and Prevention Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Gastric Cancer Testing, Treatment and Prevention Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Gastric Cancer Testing, Treatment and Prevention Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Gastric Cancer Testing, Treatment and Prevention Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Gastric Cancer Testing, Treatment and Prevention Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Gastric Cancer Testing, Treatment and Prevention Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Gastric Cancer Testing, Treatment and Prevention Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Gastric Cancer Testing, Treatment and Prevention Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Gastric Cancer Testing, Treatment and Prevention Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Gastric Cancer Testing, Treatment and Prevention Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Gastric Cancer Testing, Treatment and Prevention Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Gastric Cancer Testing, Treatment and Prevention Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Gastric Cancer Testing, Treatment and Prevention Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Gastric Cancer Testing, Treatment and Prevention Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Gastric Cancer Testing, Treatment and Prevention Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Gastric Cancer Testing, Treatment and Prevention Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Gastric Cancer Testing, Treatment and Prevention Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Gastric Cancer Testing, Treatment and Prevention Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Gastric Cancer Testing, Treatment and Prevention Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Gastric Cancer Testing, Treatment and Prevention Market Size by Country (2022-2027) & (US$ Million)
Table 62. Biogen Idec Company Details
Table 63. Biogen Idec Business Overview
Table 64. Biogen Idec Gastric Cancer Testing, Treatment and Prevention Product
Table 65. Biogen Idec Revenue in Gastric Cancer Testing, Treatment and Prevention Business (2016-2021) & (US$ Million)
Table 66. Biogen Idec Recent Development
Table 67. Bristol Myers Squibb Company Details
Table 68. Bristol Myers Squibb Business Overview
Table 69. Bristol Myers Squibb Gastric Cancer Testing, Treatment and Prevention Product
Table 70. Bristol Myers Squibb Revenue in Gastric Cancer Testing, Treatment and Prevention Business (2016-2021) & (US$ Million)
Table 71. Bristol Myers Squibb Recent Development
Table 72. Eli Lilly And Company Company Details
Table 73. Eli Lilly And Company Business Overview
Table 74. Eli Lilly And Company Gastric Cancer Testing, Treatment and Prevention Product
Table 75. Eli Lilly And Company Revenue in Gastric Cancer Testing, Treatment and Prevention Business (2016-2021) & (US$ Million)
Table 76. Eli Lilly And Company Recent Development
Table 77. Glaxosmithkline Genentech, Inc Company Details
Table 78. Glaxosmithkline Genentech, Inc Business Overview
Table 79. Glaxosmithkline Genentech, Inc Gastric Cancer Testing, Treatment and Prevention Product
Table 80. Glaxosmithkline Genentech, Inc Revenue in Gastric Cancer Testing, Treatment and Prevention Business (2016-2021) & (US$ Million)
Table 81. Glaxosmithkline Genentech, Inc Recent Development
Table 82. Hoffmann-La Roche Inc. Company Details
Table 83. Hoffmann-La Roche Inc. Business Overview
Table 84. Hoffmann-La Roche Inc. Gastric Cancer Testing, Treatment and Prevention Product
Table 85. Hoffmann-La Roche Inc. Revenue in Gastric Cancer Testing, Treatment and Prevention Business (2016-2021) & (US$ Million)
Table 86. Hoffmann-La Roche Inc. Recent Development
Table 87. Immunogen Merck & Company Company Details
Table 88. Immunogen Merck & Company Business Overview
Table 89. Immunogen Merck & Company Gastric Cancer Testing, Treatment and Prevention Product
Table 90. Immunogen Merck & Company Revenue in Gastric Cancer Testing, Treatment and Prevention Business (2016-2021) & (US$ Million)
Table 91. Immunogen Merck & Company Recent Development
Table 92. Novartis Company Details
Table 93. Novartis Business Overview
Table 94. Novartis Gastric Cancer Testing, Treatment and Prevention Product
Table 95. Novartis Revenue in Gastric Cancer Testing, Treatment and Prevention Business (2016-2021) & (US$ Million)
Table 96. Novartis Recent Development
Table 97. Pacific Edge Diagnostics Nz Company Details
Table 98. Pacific Edge Diagnostics Nz Business Overview
Table 99. Pacific Edge Diagnostics Nz Revenue in Gastric Cancer Testing, Treatment and Prevention Business (2016-2021) & (US$ Million)
Table 100. Pacific Edge Diagnostics Nz Recent Development
Table 101. Pfizer Company Details
Table 102. Pfizer Business Overview
Table 103. Pfizer Gastric Cancer Testing, Treatment and Prevention Product
Table 104. Pfizer Revenue in Gastric Cancer Testing, Treatment and Prevention Business (2016-2021) & (US$ Million)
Table 105. Pfizer Recent Development
Table 106. Roche/Genentech Oncolytics Company Details
Table 107. Roche/Genentech Oncolytics Business Overview
Table 108. Roche/Genentech Oncolytics Gastric Cancer Testing, Treatment and Prevention Product
Table 109. Roche/Genentech Oncolytics Revenue in Gastric Cancer Testing, Treatment and Prevention Business (2016-2021) & (US$ Million)
Table 110. Roche/Genentech Oncolytics Recent Development
Table 111. Zova Biotherapeutics Inc. Company Details
Table 112. Zova Biotherapeutics Inc. Business Overview
Table 113. Zova Biotherapeutics Inc. Gastric Cancer Testing, Treatment and Prevention Product
Table 114. Zova Biotherapeutics Inc. Revenue in Gastric Cancer Testing, Treatment and Prevention Business (2016-2021) & (US$ Million)
Table 115. Zova Biotherapeutics Inc. Recent Development
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Gastric Cancer Testing, Treatment and Prevention Market Share by Type: 2020 VS 2027
Figure 2. Test Features
Figure 3. Treatment Features
Figure 4. Prevention Features
Figure 5. Global Gastric Cancer Testing, Treatment and Prevention Market Share by Application: 2020 VS 2027
Figure 6. Hospitals Case Studies
Figure 7. Clinics Case Studies
Figure 8. Other Case Studies
Figure 9. Gastric Cancer Testing, Treatment and Prevention Report Years Considered
Figure 10. Global Gastric Cancer Testing, Treatment and Prevention Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Gastric Cancer Testing, Treatment and Prevention Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Gastric Cancer Testing, Treatment and Prevention Market Share by Regions: 2020 VS 2027
Figure 13. Global Gastric Cancer Testing, Treatment and Prevention Market Share by Regions (2022-2027)
Figure 14. Global Gastric Cancer Testing, Treatment and Prevention Market Share by Players in 2020
Figure 15. Global Top Gastric Cancer Testing, Treatment and Prevention Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gastric Cancer Testing, Treatment and Prevention as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Gastric Cancer Testing, Treatment and Prevention Revenue in 2020
Figure 17. Global Gastric Cancer Testing, Treatment and Prevention Revenue Market Share by Type (2016-2021)
Figure 18. Global Gastric Cancer Testing, Treatment and Prevention Revenue Market Share by Type (2022-2027)
Figure 19. North America Gastric Cancer Testing, Treatment and Prevention Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Gastric Cancer Testing, Treatment and Prevention Market Share by Type (2016-2027)
Figure 21. North America Gastric Cancer Testing, Treatment and Prevention Market Share by Application (2016-2027)
Figure 22. North America Gastric Cancer Testing, Treatment and Prevention Market Share by Country (2016-2027)
Figure 23. United States Gastric Cancer Testing, Treatment and Prevention Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Gastric Cancer Testing, Treatment and Prevention Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Gastric Cancer Testing, Treatment and Prevention Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Gastric Cancer Testing, Treatment and Prevention Market Share by Type (2016-2027)
Figure 27. Europe Gastric Cancer Testing, Treatment and Prevention Market Share by Application (2016-2027)
Figure 28. Europe Gastric Cancer Testing, Treatment and Prevention Market Share by Country (2016-2027)
Figure 29. Germany Gastric Cancer Testing, Treatment and Prevention Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Gastric Cancer Testing, Treatment and Prevention Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Gastric Cancer Testing, Treatment and Prevention Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Gastric Cancer Testing, Treatment and Prevention Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Gastric Cancer Testing, Treatment and Prevention Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Gastric Cancer Testing, Treatment and Prevention Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Gastric Cancer Testing, Treatment and Prevention Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Gastric Cancer Testing, Treatment and Prevention Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Gastric Cancer Testing, Treatment and Prevention Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Gastric Cancer Testing, Treatment and Prevention Market Share by Region (2016-2027)
Figure 39. China Gastric Cancer Testing, Treatment and Prevention Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Gastric Cancer Testing, Treatment and Prevention Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Gastric Cancer Testing, Treatment and Prevention Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Gastric Cancer Testing, Treatment and Prevention Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Gastric Cancer Testing, Treatment and Prevention Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Gastric Cancer Testing, Treatment and Prevention Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Gastric Cancer Testing, Treatment and Prevention Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Gastric Cancer Testing, Treatment and Prevention Market Share by Type (2016-2027)
Figure 47. Latin America Gastric Cancer Testing, Treatment and Prevention Market Share by Application (2016-2027)
Figure 48. Latin America Gastric Cancer Testing, Treatment and Prevention Market Share by Country (2016-2027)
Figure 49. Mexico Gastric Cancer Testing, Treatment and Prevention Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Gastric Cancer Testing, Treatment and Prevention Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Gastric Cancer Testing, Treatment and Prevention Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Gastric Cancer Testing, Treatment and Prevention Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Gastric Cancer Testing, Treatment and Prevention Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Gastric Cancer Testing, Treatment and Prevention Market Share by Country (2016-2027)
Figure 55. Turkey Gastric Cancer Testing, Treatment and Prevention Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Gastric Cancer Testing, Treatment and Prevention Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Gastric Cancer Testing, Treatment and Prevention Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Biogen Idec Revenue Growth Rate in Gastric Cancer Testing, Treatment and Prevention Business (2016-2021)
Figure 59. Bristol Myers Squibb Revenue Growth Rate in Gastric Cancer Testing, Treatment and Prevention Business (2016-2021)
Figure 60. Eli Lilly And Company Revenue Growth Rate in Gastric Cancer Testing, Treatment and Prevention Business (2016-2021)
Figure 61. Glaxosmithkline Genentech, Inc Revenue Growth Rate in Gastric Cancer Testing, Treatment and Prevention Business (2016-2021)
Figure 62. Hoffmann-La Roche Inc. Revenue Growth Rate in Gastric Cancer Testing, Treatment and Prevention Business (2016-2021)
Figure 63. Immunogen Merck & Company Revenue Growth Rate in Gastric Cancer Testing, Treatment and Prevention Business (2016-2021)
Figure 64. Novartis Revenue Growth Rate in Gastric Cancer Testing, Treatment and Prevention Business (2016-2021)
Figure 65. Pacific Edge Diagnostics Nz Revenue Growth Rate in Gastric Cancer Testing, Treatment and Prevention Business (2016-2021)
Figure 66. Pfizer Revenue Growth Rate in Gastric Cancer Testing, Treatment and Prevention Business (2016-2021)
Figure 67. Roche/Genentech Oncolytics Revenue Growth Rate in Gastric Cancer Testing, Treatment and Prevention Business (2016-2021)
Figure 68. Zova Biotherapeutics Inc. Revenue Growth Rate in Gastric Cancer Testing, Treatment and Prevention Business (2016-2021)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed

---